News & Updates
Showing Pharmacy articles
Showing
Show Multimedia Only

Enfortumab vedotin-pembrolizumab beats chemo as 1L Tx for bladder cancer
03 Nov 2023
byAudrey Abella
In the phase III EV-302/KEYNOTE-A39 trial, the combination of enfortumab vedotin and pembrolizumab (EV+P) had a significant survival advantage over chemotherapy in the first-line treatment of patients with locally advanced metastatic urothelial carcinoma (la/mUC).
03 Nov 2023

Esketamine outperforms quetiapine in head-to-head depression trial
30 Oct 2023
byJairia Dela Cruz
In patients with treatment-resistant depression, esketamine nasal spray appears to have superior efficacy compared with extended-release quetiapine when used in combination with conventional antidepressants.
30 Oct 2023

Antiviral therapy safe, effective in children with immune-tolerant HBV infection
28 Oct 2023
Treatment with antiviral therapy is beneficial and generally tolerated in children with chronic hepatitis B virus (HBV) infection in the immune-tolerant stage, according to the results of a systematic review and meta-analysis.
28 Oct 2023






